AMUSSEN HUNSAKER ASSOCIATES LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 121 filers reported holding VIKING THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMUSSEN HUNSAKER ASSOCIATES LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$206,612
+217.9%
21,980
-8.3%
0.06%
+216.7%
Q3 2022$65,000
-5.8%
23,9800.0%0.02%
-5.3%
Q2 2022$69,000
-4.2%
23,9800.0%0.02%
+18.8%
Q1 2022$72,000
-34.5%
23,9800.0%0.02%
-38.5%
Q4 2021$110,000
-63.3%
23,980
-50.0%
0.03%
-18.8%
Q3 2021$300,000
+106.9%
47,960
+100.0%
0.03%
-22.0%
Q2 2021$145,000
+35.5%
23,980
+26.0%
0.04%
+5.1%
Q4 2020$107,000
-3.6%
19,0300.0%0.04%
-17.0%
Q3 2020$111,000
-15.3%
19,030
+4.4%
0.05%
-26.6%
Q2 2020$131,000
+8.3%
18,230
-29.5%
0.06%
-22.0%
Q1 2020$121,000
-41.5%
25,8700.0%0.08%
-30.5%
Q4 2019$207,000
+16.3%
25,8700.0%0.12%
+9.3%
Q3 2019$178,000
-17.2%
25,8700.0%0.11%
-24.5%
Q2 2019$215,000
-16.3%
25,8700.0%0.14%
+38.8%
Q1 2019$257,000
+29.8%
25,8700.0%0.10%
-29.9%
Q4 2018$198,000
-37.7%
25,870
-10.9%
0.15%
-29.0%
Q3 2018$318,000
+174.1%
29,020
+136.9%
0.21%
+143.5%
Q2 2018$116,000
+118.9%
12,248
+1.7%
0.08%
+112.5%
Q1 2018$53,000
+20.5%
12,048
+11.8%
0.04%
+8.1%
Q4 2017$44,00010,7780.04%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders